$109 Million is the total value of HealthCor Management, L.P.'s 22 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 84.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $38,059,999 | -40.8% | 367,765 | -51.5% | 34.88% | +333.5% |
DXCM | Buy | DEXCOM INC | $36,393,071 | +78.2% | 321,380 | +26.8% | 33.35% | +1206.5% |
CYTK | Sell | CYTOKINETICS INC | $7,534,640 | -64.2% | 164,440 | -62.2% | 6.90% | +162.2% |
New | ACRIVON THERAPEUTICS INC | $3,273,995 | – | 284,201 | +100.0% | 3.00% | – | |
Buy | HYPERFINE INC | $3,259,956 | +46.4% | 3,880,900 | +41.2% | 2.99% | +971.0% | |
ALKS | Sell | ALKERMES PLC | $2,874,300 | -57.6% | 110,000 | -63.8% | 2.63% | +210.6% |
CNMD | New | CONMED CORP | $2,437,600 | – | 27,500 | +100.0% | 2.23% | – |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $2,388,800 | +3.5% | 20,000 | -7.9% | 2.19% | +657.4% |
SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $1,781,500 | -91.4% | 70,000 | -91.9% | 1.63% | -36.8% |
KDNY | Sell | CHINOOK THERAPEUTICS INC | $1,572,000 | -70.0% | 60,000 | -77.5% | 1.44% | +119.7% |
ISRG | New | INTUITIVE SURGICAL INC | $1,525,762 | – | 5,750 | +100.0% | 1.40% | – |
BPMC | Sell | BLUEPRINT MEDICINES CORP | $1,314,300 | -80.9% | 30,000 | -71.3% | 1.20% | +39.8% |
GERN | Sell | GERON CORP | $1,210,000 | -72.8% | 500,000 | -73.7% | 1.11% | +99.1% |
PEN | New | PENUMBRA INC | $1,112,300 | – | 5,000 | +100.0% | 1.02% | – |
RCKT | Sell | ROCKET PHARMACEUTICALS INC | $978,500 | -86.2% | 50,000 | -88.8% | 0.90% | +1.0% |
RAIN | New | RAIN ONCOLOGY INC | $960,000 | – | 120,000 | +100.0% | 0.88% | – |
INSP | Sell | INSPIRE MED SYS INC | $881,580 | -87.0% | 3,500 | -90.8% | 0.81% | -4.7% |
SILK | New | SILK RD MED INC | $792,750 | – | 15,000 | +100.0% | 0.73% | – |
IMGN | Sell | IMMUNOGEN INC | $744,000 | -88.0% | 150,000 | -88.5% | 0.68% | -12.2% |
EQRX INC*w exp 12/17/202 | $9,451 | -67.4% | 35,239 | 0.0% | 0.01% | +125.0% | ||
EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $4,340 | +117.0% | 78,059 | 0.0% | 0.00% | – | |
MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $2,679 | +167.9% | 29,776 | 0.0% | 0.00% | – | |
OHPAW | Exit | ORION ACQUISITION CORP*w exp 02/19/202 | $0 | – | -50,105 | -100.0% | 0.00% | – |
LGVWS | Exit | LONGVIEW ACQUISITION CORP II*w exp 99/99/999 | $0 | – | -149,999 | -100.0% | -0.00% | – |
IKNA | Exit | IKENA ONCOLOGY INC | $0 | – | -220,082 | -100.0% | -0.10% | – |
LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -1,066,689 | -100.0% | -0.12% | – |
ISEE | Exit | IVERIC BIO INC | $0 | – | -85,230 | -100.0% | -0.19% | – |
RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -64,590 | -100.0% | -0.22% | – |
NTRA | Exit | NATERA INC | $0 | – | -65,130 | -100.0% | -0.36% | – |
BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -455,000 | -100.0% | -0.36% | – |
NVRO | Exit | NEVRO CORP | $0 | – | -67,600 | -100.0% | -0.39% | – |
NEO | Exit | NEOGENOMICS INC | $0 | – | -391,110 | -100.0% | -0.42% | – |
CANO | Exit | CANO HEALTH INC | $0 | – | -395,560 | -100.0% | -0.43% | – |
AFMD | Exit | AFFIMED N V | $0 | – | -1,721,925 | -100.0% | -0.44% | – |
XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -158,200 | -100.0% | -0.56% | – |
MRUS | Exit | MERUS N V | $0 | – | -272,890 | -100.0% | -0.68% | – |
SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -19,720 | -100.0% | -0.69% | – |
SGEN | Exit | SEAGEN INC | $0 | – | -57,340 | -100.0% | -0.98% | – |
HOLX | Exit | HOLOGIC INC | $0 | – | -137,330 | -100.0% | -1.11% | – |
MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -27,540 | -100.0% | -1.14% | – |
ABT | Exit | ABBOTT LABS | $0 | – | -98,970 | -100.0% | -1.20% | – |
MCK | Exit | MCKESSON CORP | $0 | – | -35,040 | -100.0% | -1.49% | – |
CVS | Exit | CVS HEALTH CORP | $0 | – | -131,150 | -100.0% | -1.56% | – |
KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -1,607,650 | -100.0% | -1.73% | – |
BDX | Exit | BECTON DICKINSON & CO | $0 | – | -62,930 | -100.0% | -1.75% | – |
HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -229,530 | -100.0% | -1.78% | – |
INCY | Exit | INCYTE CORP | $0 | – | -227,851 | -100.0% | -1.90% | – |
BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -223,150 | -100.0% | -1.98% | – |
HSIC | Exit | HENRY SCHEIN INC | $0 | – | -248,920 | -100.0% | -2.05% | – |
LIVN | Exit | LIVANOVA PLC | $0 | – | -328,030 | -100.0% | -2.08% | – |
AMGN | Exit | AMGEN INC | $0 | – | -75,370 | -100.0% | -2.12% | – |
ANTM | Exit | ELEVANCE HEALTH INC | $0 | – | -38,910 | -100.0% | -2.21% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -69,950 | -100.0% | -2.34% | – |
HUM | Exit | HUMANA INC | $0 | – | -42,920 | -100.0% | -2.60% | – |
CI | Exit | CIGNA CORP NEW | $0 | – | -76,910 | -100.0% | -2.67% | – |
CNC | Exit | CENTENE CORP DEL | $0 | – | -300,970 | -100.0% | -2.93% | – |
TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -51,240 | -100.0% | -3.25% | – |
THC | Exit | TENET HEALTHCARE CORP | $0 | – | -518,990 | -100.0% | -3.35% | – |
DHR | Exit | DANAHER CORPORATION | $0 | – | -117,800 | -100.0% | -3.80% | – |
UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -62,980 | -100.0% | -3.98% | – |
ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -239,150 | -100.0% | -4.05% | – |
LLY | Exit | LILLY ELI & CO | $0 | – | -103,150 | -100.0% | -4.17% | – |
BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -958,600 | -100.0% | -4.64% | – |
A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -338,030 | -100.0% | -5.14% | – |
ABBV | Exit | ABBVIE INC | $0 | – | -310,250 | -100.0% | -5.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
HUMANA INC | 22 | Q3 2022 | 6.6% |
BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
BIOGEN INC | 21 | Q3 2022 | 8.5% |
LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2023-05-26 |
4 | 2023-05-26 |
SC 13D/A | 2023-05-26 |
4 | 2023-04-04 |
4 | 2023-04-04 |
SC 13D/A | 2023-04-03 |
13F-HR | 2023-02-15 |
SC 13G/A | 2023-02-14 |
4 | 2023-01-04 |
4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.